MMSI Stock Forecast 2025-2026
Distance to MMSI Price Targets
MMSI Price Momentum
10 Quality Stocks Worth Considering Now
Researching Merit Medical (MMSI) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MMSI and similar high-potential opportunities.
Latest MMSI Stock Price Targets & Analyst Predictions
Based on our analysis of 16 Wall Street analysts, MMSI has a bullish consensus with a median price target of $116.00 (ranging from $111.00 to $128.00). The overall analyst rating is Strong Buy (8.7/10). Currently trading at $90.89, the median forecast implies a 27.6% upside. This outlook is supported by 10 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Jon Young at Canaccord Genuity, projecting a 40.8% upside. Conversely, the most conservative target is provided by Michael Petusky at Barrington Research, suggesting a 22.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MMSI Analyst Ratings
MMSI Price Target Range
Latest MMSI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MMSI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 11, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $111.00 |
| Apr 9, 2025 | Needham | Mike Matson | Buy | Reiterates | $116.00 |
| Mar 28, 2025 | JP Morgan | Robbie Marcus | Overweight | Initiates | $120.00 |
| Feb 26, 2025 | Canaccord Genuity | Jon Young | Buy | Maintains | $127.00 |
| Feb 26, 2025 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $117.00 |
| Feb 26, 2025 | Needham | Mike Matson | Buy | Maintains | $116.00 |
| Feb 26, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $111.00 |
| Jan 29, 2025 | Piper Sandler | Jason Bednar | Overweight | Reiterates | $116.00 |
| Jan 29, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $115.00 |
| Jan 29, 2025 | Canaccord Genuity | Jon Young | Buy | Maintains | $128.00 |
| Jan 29, 2025 | Needham | Mike Matson | Buy | Maintains | $122.00 |
| Jan 21, 2025 | Piper Sandler | Jason Bednar | Overweight | Maintains | $114.00 |
| Jan 14, 2025 | Needham | Mike Matson | Buy | Reiterates | $109.00 |
| Dec 31, 2024 | Raymond James | Jayson Bedford | Outperform | Maintains | $110.00 |
| Dec 23, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $114.00 |
| Dec 11, 2024 | Wells Fargo | Larry Biegelsen | Overweight | Upgrade | $120.00 |
| Dec 9, 2024 | Canaccord Genuity | Jon Young | Buy | Maintains | $127.00 |
| Oct 31, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $114.00 |
| Oct 31, 2024 | Needham | Mike Matson | Buy | Reiterates | $109.00 |
| Oct 31, 2024 | Baird | David Rescott | Outperform | Maintains | $109.00 |
Merit Medical Systems, Inc. (MMSI) Competitors
The following stocks are similar to Merit Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Merit Medical Systems, Inc. (MMSI) Financial Data
Merit Medical Systems, Inc. has a market capitalization of $5.37B with a P/E ratio of 44.8x. The company generates $1.36B in trailing twelve-month revenue with a 8.9% profit margin.
Revenue growth is +9.4% quarter-over-quarter, while maintaining an operating margin of +11.2% and return on equity of +9.3%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Merit Medical Systems, Inc. (MMSI) Business Model
About Merit Medical Systems, Inc.
Develops and manufactures medical devices for healthcare.
Merit Medical Systems generates revenue through the design, manufacturing, and distribution of a wide range of medical devices aimed at diagnostic and interventional procedures. Their products, including catheters and procedural kits, are sold to healthcare providers globally, ensuring a steady income stream from a diverse customer base.
Founded in 1987 and headquartered in South Jordan, Utah, the company emphasizes innovation and high-quality standards to meet the evolving needs of the healthcare sector. Merit Medical's strong global presence and commitment to improving patient care make it a significant player in the healthcare industry.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
7,400
CEO
Mr. Fred P. Lampropoulos
Country
United States
IPO Year
1992
Website
www.merit.comMerit Medical Systems, Inc. (MMSI) Latest News & Analysis
Merit Medical (MMSI) is expected to report earnings that may exceed forecasts, driven by favorable conditions. Investors should monitor the upcoming earnings report closely.
Merit Medical's potential earnings beat signals strong financial performance, which could positively influence stock prices and investor confidence.
Merit Medical (MMSI) has a strong history of earnings surprises and is positioned well for a potential earnings beat in its upcoming quarterly report.
Merit Medical's strong earnings surprise history and favorable conditions suggest potential for positive performance, influencing stock price and investor sentiment ahead of the quarterly report.
MMSI has launched the Ventrax Delivery System, designed to improve control, precision, and efficiency in pulmonary access procedures for interventionalists.
MMSI's launch of the Ventrax Delivery System may boost sales and market share, signaling growth potential and innovation, which can positively impact stock performance and investor sentiment.
Four dental supply stocks to consider for investment are CAH, MMSI, XRAY, and CNMD, as they are expected to generate wealth for investors.
Highlighting stocks in the Dental Supplies industry suggests potential growth opportunities, signaling investment interest and possible returns for those companies.
A new all-in-one retrograde aortic access delivery system has been developed to enhance the treatment of ventricular tachycardia, potentially benefiting medical device companies in this sector.
The advancement in aortic access delivery systems enhances treatment efficiency for ventricular tachycardia, potentially increasing market demand and driving growth for companies in cardiac care.
Merit Medical (MMSI) saw a rise in share price with higher trading volume, but recent earnings estimate revisions indicate potential weakness ahead.
Merit Medical's rising share price on high volume indicates short-term interest, but stagnant earnings estimates may signal potential weakness ahead, affecting long-term investment decisions.
Frequently Asked Questions About MMSI Stock
What is Merit Medical Systems, Inc.'s (MMSI) stock forecast for 2025?
Based on our analysis of 16 Wall Street analysts, Merit Medical Systems, Inc. (MMSI) has a median price target of $116.00. The highest price target is $128.00 and the lowest is $111.00.
Is MMSI stock a good investment in 2025?
According to current analyst ratings, MMSI has 10 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $90.89. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MMSI stock?
Wall Street analysts predict MMSI stock could reach $116.00 in the next 12 months. This represents a 27.6% increase from the current price of $90.89. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Merit Medical Systems, Inc.'s business model?
Merit Medical Systems generates revenue through the design, manufacturing, and distribution of a wide range of medical devices aimed at diagnostic and interventional procedures. Their products, including catheters and procedural kits, are sold to healthcare providers globally, ensuring a steady income stream from a diverse customer base.
What is the highest forecasted price for MMSI Merit Medical Systems, Inc.?
The highest price target for MMSI is $128.00 from Jon Young at Canaccord Genuity, which represents a 40.8% increase from the current price of $90.89.
What is the lowest forecasted price for MMSI Merit Medical Systems, Inc.?
The lowest price target for MMSI is $111.00 from Michael Petusky at Barrington Research, which represents a 22.1% increase from the current price of $90.89.
What is the overall MMSI consensus from analysts for Merit Medical Systems, Inc.?
The overall analyst consensus for MMSI is bullish. Out of 16 Wall Street analysts, 10 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $116.00.
How accurate are MMSI stock price projections?
Stock price projections, including those for Merit Medical Systems, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.